Cargo Therapeutics to be acquired by Concentra for $4.379/sh cash plus CVR

CARGO Therapeutics, Inc.

Per-share consideration: $4.379 cash plus one CVR representing 100% of net cash above $217.5M and 80% of disposition proceeds of certain pipeline assets.
Tender offer to launch by July 21, 2025; closing requires tender of >50% of outstanding shares and closing net cash ≥$217.5M.
Directors, officers and certain stockholders owning ~17.4% of shares have agreed to tender and support the deal.
CVR rights are non-transferable; any payments from asset dispositions must occur within two years of closing.
Board unanimously approved; no financing condition; termination fee of $3.8M in certain circumstances.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.